Cargando…

Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes

OBJECTIVE: This study investigates how the excess risk of lower extremity amputations (amputations) in people with type 1 diabetes mellitus (DM) differs from the general population by diabetes duration, glycemic control, and renal complications. RESEARCH DESIGN AND METHODS: We analyzed data from peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ólafsdóttir, Arndís Finna, Svensson, Ann-Marie, Pivodic, Aldina, Gudbjörnsdottir, Soffia, Nyström, Thomas, Wedel, Hans, Rosengren, Annika, Lind, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501853/
https://www.ncbi.nlm.nih.gov/pubmed/31114696
http://dx.doi.org/10.1136/bmjdrc-2018-000602
_version_ 1783416160223494144
author Ólafsdóttir, Arndís Finna
Svensson, Ann-Marie
Pivodic, Aldina
Gudbjörnsdottir, Soffia
Nyström, Thomas
Wedel, Hans
Rosengren, Annika
Lind, Marcus
author_facet Ólafsdóttir, Arndís Finna
Svensson, Ann-Marie
Pivodic, Aldina
Gudbjörnsdottir, Soffia
Nyström, Thomas
Wedel, Hans
Rosengren, Annika
Lind, Marcus
author_sort Ólafsdóttir, Arndís Finna
collection PubMed
description OBJECTIVE: This study investigates how the excess risk of lower extremity amputations (amputations) in people with type 1 diabetes mellitus (DM) differs from the general population by diabetes duration, glycemic control, and renal complications. RESEARCH DESIGN AND METHODS: We analyzed data from people with type 1 DM from the Swedish National Diabetes Register without prior amputation from January 1998 to December 2013. Each person (n=36 872) was randomly matched with five controls by sex, age, and county (n=184 360) from the population without diabetes. All were followed until first amputation, death or end of follow-up. RESULTS: The overall adjusted HR for all amputation was 40.1 (95% CI 32.8 to 49.1) for type 1 DM versus controls. HR increased with longer diabetes duration. The incidence of amputation/1000 patient-years was 3.18 (95% CI 2.99 to 3.38) for type 1 DM and 0.07 (95% CI 0.05 to 0.08) for controls. The incidence decreased from 1998–2001 (3.09, 95% CI 2.56 to 3.62) to 2011–2013 (2.64, 95% CI 2.31 to 2.98). The HR for major amputations was lower than for minor amputations and decreased over the time period (p=0.0045). Worsening in glycemic control among patients with diabetes led to increased risk for amputation with an HR of 1.80 (95% CI 1.72 to 1.88) per 10 mmol/mol (1%) increase in hemoglobin A1c. CONCLUSIONS: Although the absolute risk of amputation is relatively low, the overall excess risk was 40 times that of controls. Excess risk was substantially lower for those with good glycemic control and without renal complications, but excess risk still existed and is greatest for minor amputations.
format Online
Article
Text
id pubmed-6501853
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65018532019-05-21 Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes Ólafsdóttir, Arndís Finna Svensson, Ann-Marie Pivodic, Aldina Gudbjörnsdottir, Soffia Nyström, Thomas Wedel, Hans Rosengren, Annika Lind, Marcus BMJ Open Diabetes Res Care Epidemiology/Health Services Research OBJECTIVE: This study investigates how the excess risk of lower extremity amputations (amputations) in people with type 1 diabetes mellitus (DM) differs from the general population by diabetes duration, glycemic control, and renal complications. RESEARCH DESIGN AND METHODS: We analyzed data from people with type 1 DM from the Swedish National Diabetes Register without prior amputation from January 1998 to December 2013. Each person (n=36 872) was randomly matched with five controls by sex, age, and county (n=184 360) from the population without diabetes. All were followed until first amputation, death or end of follow-up. RESULTS: The overall adjusted HR for all amputation was 40.1 (95% CI 32.8 to 49.1) for type 1 DM versus controls. HR increased with longer diabetes duration. The incidence of amputation/1000 patient-years was 3.18 (95% CI 2.99 to 3.38) for type 1 DM and 0.07 (95% CI 0.05 to 0.08) for controls. The incidence decreased from 1998–2001 (3.09, 95% CI 2.56 to 3.62) to 2011–2013 (2.64, 95% CI 2.31 to 2.98). The HR for major amputations was lower than for minor amputations and decreased over the time period (p=0.0045). Worsening in glycemic control among patients with diabetes led to increased risk for amputation with an HR of 1.80 (95% CI 1.72 to 1.88) per 10 mmol/mol (1%) increase in hemoglobin A1c. CONCLUSIONS: Although the absolute risk of amputation is relatively low, the overall excess risk was 40 times that of controls. Excess risk was substantially lower for those with good glycemic control and without renal complications, but excess risk still existed and is greatest for minor amputations. BMJ Publishing Group 2019-04-14 /pmc/articles/PMC6501853/ /pubmed/31114696 http://dx.doi.org/10.1136/bmjdrc-2018-000602 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology/Health Services Research
Ólafsdóttir, Arndís Finna
Svensson, Ann-Marie
Pivodic, Aldina
Gudbjörnsdottir, Soffia
Nyström, Thomas
Wedel, Hans
Rosengren, Annika
Lind, Marcus
Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
title Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
title_full Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
title_fullStr Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
title_full_unstemmed Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
title_short Excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
title_sort excess risk of lower extremity amputations in people with type 1 diabetes compared with the general population: amputations and type 1 diabetes
topic Epidemiology/Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501853/
https://www.ncbi.nlm.nih.gov/pubmed/31114696
http://dx.doi.org/10.1136/bmjdrc-2018-000602
work_keys_str_mv AT olafsdottirarndisfinna excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes
AT svenssonannmarie excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes
AT pivodicaldina excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes
AT gudbjornsdottirsoffia excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes
AT nystromthomas excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes
AT wedelhans excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes
AT rosengrenannika excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes
AT lindmarcus excessriskoflowerextremityamputationsinpeoplewithtype1diabetescomparedwiththegeneralpopulationamputationsandtype1diabetes